E2F1 and colorectal carcinoma: On the other hand, although E2F1 seems to be one of several potential predictors for response to 5FU-based therapy, because it controls the transcription of genes encoding proteins engaged in DNA synthesis including TS, little is known on the association of E2F1 protein expression and survival of patients with CRC.